Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Sethi, Sunil ^a   Mewara, Abhishek ^a   Dhatwalia, Sunil Kumar ^a   Singh, Harpal ^a   Yadav, Rakesh ^a   Singh, Khushwinder ^a   Gupta, Dheeraj ^a   Wanchu, Ajay ^a   Sharma, Meera ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Extensively drug resistant; HIV; Multidrug resistant; Mycobacterium tuberculosis; Socioeconomic status

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PREVALENCE; SCHOOL CHILD; SEROLOGY TEST KIT; SOCIAL STATUS; SPUTUM CYTODIAGNOSIS; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84874940645     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-137     Document Type: Article

References (27)

1. World Health Organization Global Tuberculosis Control: WHO report 2011 Available: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf. Accessed 26 March, 2013, World Health Organization.
2. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and respons Available: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf. Accessed 26 March, 2013, World Health Organization.
3. Thaiss WM, Thaiss CC, Thaiss CA. Recent developments in the epidemiology and management of tuberculosis - new solutions to old problems?. Infect Drug Resist 2012, 5:1-8.
4. Paramasivan CN. An overview of drug resistant tuberculosis in India. Ind J Tuberc 1998, 45:73-81.
5. Paramasivan CN, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004, 120:377-386.
6. Chauhan LS. Drug resistant TB-RNTCP response (P.K. Sen-TAI Gold Medal oration delivered at the 62nd National Conference on Tuberculosis & Chest Diseases held in New Delhi from 14th to 16th December, 2007). Indian J Tuberc 2008, 55(1):5-8.
7. National AIDS Control Organization, India NACO Guidelines on HIV testing Available: http://nacoonline.org/upload/Policies%20%20Guidelines/5-GUILDELINES%20FOR%20HIV%20TESTING.pdf. Accessed 26 March, 2013, National AIDS Control Organization, India.
8. Vestal AL. Procedures for isolation and identification of Mycobacteria 1997, 15-19. CDC Atlanta, Georgia: U.S. Department of Health, Education and Welfare, Publication No CDC-77-8230.
9. Canetti G, Froman F, Grosset J, Hauduroy P, Langerova M, Mahler HT, Meissner G, Mitchison DA, Sula L. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. WHO 1963, 41:21-43.
10. Rüsch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 2006, 44(3):688-692.
11. Sharma SK, Kaushik G, Jha B, George N, Arora SK, Gupta D, Singh U, Hanif M, Vashisht RP. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian J Med Res 2011, 133:308-311.
12. Jain NK, Chopra KK, Prasad G. Initial and acquired isoniazid and rifampicin resistance to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992, 39:12-14.
13. D'souza DT, Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvol G, Nicol M, Wilkinson RJ. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Publ Health 2009, 9:211.
14. Sharma SK, Kumar S, Saha PK, George N, Arora SK, Gupta D, Singh U, Hanif M, Vashisht RP. Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients. Indian J Med Res 2011, 133:312-315.
15. Vijay S, Bala Sangameshwara VJ, Jagannatha PS, Kumar P. Initial drug resistance among tuberculosis patients under DOTS Programme in Bangalore City. Indian J Tuberc 2004, 51:17-21.
16. Shah AR, Agarwal SK, Shah KV. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Int J Tuberc Lung Dis 2002, 6(12):1098-1101.
17. Hanif M, Malik S, Dhingra VK. Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India. Int J Tuberc Lung Dis 2009, 13(1):74-78.
18. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006, 368(9547):1575-1580.
19. World Health Organization 2006 Emergence of XDR-TB. WHO concern over extensive drug resistant TB strains that are virtually untreatable http://www.who.int/mediacentre/news/notes/2006/np23/en/index.html. Accessed 17 January 2012, World Health Organization 2006.
20. Mondal R, Jain A. Extensively drug-resistant Mycobacterium tuberculosis isolates, India. Emerg Infect Dis 2007, 13(9):1429-1431.
21. Jain NK, Agnihotri SP, Sharma KK, Gupta S, Gupta P. Extensively Drug resistance (XDR) TB is not always fatal. Indian J Tuberc 2009, 56:48-50.
22. Balaji V, Daley P, Anand AA, Sudarsanam T, Michael JS, Sahni RD, Chordia P, George IA, Thomas K, Ganesh A, John KR, Mathai D. Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PLoS One 2010, 5(3):e9527.
23. Samuel NM, Alamelu C, Jagannath K, Rajan B. Detection of HIV infection in pulmonary tuberculosis patients. J Indian Med Assoc 1996, 94(9):331-333.
24. Tripathy S, Joshi DR, Mehendale SM, Menon P, Joshi AN. Sentinel survelliance for HIV infection in tuberculosis patients in India. Indian J Tuber 2002, 49:17-20.
25. Gupta S, Shenoy VP, Mukhopadhyay C, Bairy I, Muralidharan S. Role of risk factors and socio-economic status in pulmonary tuberculosis: a search for the root cause in patients in a tertiary care hospital, South India. Trop Med Int Health 2011, 16(1):74-78.
26. Shetty N, Shemko M, Vaz M, D'souza G. An epidemiological evaluation of risk factors for tuberculosis in south India: a matched case control study. Int J Tuberc Lung Dis 2006, 10(1):80-86.
27. Khan QH. Epidemiology of pulmonary tuberculosis in rural Aligarh. Indian J Community Med 2006, 31(1):39-40.